COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,722 Articles (22,913 medRxiv, 8,809 bioRxiv)

Most recent first Previous |  Page 662: Articles 6611-6620  | Next

Distinct phenotype of SARS-CoV-2 Omicron BA.1 in human primary cells but no increased host range in cell lines of putative mammalian reservoir species
Essaidi-Laziosi, M., Perez Rodriguez, F. J., Alvarez, C., Sattonnet-Roche, P., Torriani, G., Bekliz, M., Adea, K., Lenk, M., Preiser, W., Suliman, T., Muller, M. A., Drosten, C., Kaiser, L., Eckerle, I.
10.1101/2022.10.04.510352 — Posted: 2022-10-04
SARS-CoV-2 ORF3c impairs mitochondrial respiratory metabolism, oxidative stress and autophagic flow
Mozzi, A., Oldani, M., Forcella, M. E., Vantaggiato, C., Cappelletti, G., Pontremoli, C., Valenti, F., Forni, D., Biasin, M., Sironi, M., Fusi, P., Cagliani, R.
10.1101/2022.10.04.510754 — Posted: 2022-10-04
An agent-based modeling approach for lung fibrosis in response to COVID-19
Islam, M. A., Getz, M., Macklin, P., Versypt, A. N. F.
10.1101/2022.10.03.510677 — Posted: 2022-10-04
Relevance of the viral Spike protein/cellular Estrogen Receptor-α interaction for endothelial-based coagulopathy induced by SARS-CoV-2
Barbieri, S. S., Cattani, F., Sandrini, L., Grillo, M. M., Talarico, C., Iaconis, D., Lione, L., Salvatori, E., Amadio, P., Garoffolo, G., Maffei, M., Galli, F., Beccari, A. R., Marra, E., Zoppi, M., Michaelides, M., Roscilli, G., Aurisicchio, L., Bertini, R., Allegretti, M., Pesce, M.
10.1101/2022.10.04.510657 — Posted: 2022-10-04
Impact of Fluvoxamine on outpatient treatment of COVID-19 in Honduras
Pineda, E., Singh, J., Pineda, M. F. V., Umanzor, J. R. G., Baires, F., Benitez, L., Burgos, C., Sekhon, A. K., Crisp, N., Lewis, A. S., Radwanski, J., Bermudez, M., Barjun, K. S., Diaz, O., Palou, E., Escalante, R. E., Hernandez, C. I., Stevens, M. L., Eberhard, D., Sierra, M., Alvarado, T., Videa, O., Sierra-Hoffman, M., Ramon Valerio, F.
10.1101/2022.09.27.22280428 — Posted: 2022-10-04
Minor intron containing genes: Achilles' heel of viruses?
Wuchty, S., White, A. K., Olthof, A. M., Drake, K., Hume, A. J., Olejnik, J., Muehlberger, E., Aguiar-Pulido, V., Kanadia, R. N.
10.1101/2022.09.30.510319 — Posted: 2022-10-04
Immune responses of the third dose of AZD1222 vaccine or BNT162b2 mRNA vaccine after two doses of CoronaVac vaccines against Delta and Omicron variants
Niyomnaitham, S., Jongkaewwattana, A., Meesing, A., Chusri, S., Nanthapisal, S., Hirankarn, N., Siwamogsatham, S., Kirdlarp, S., Chaiwarith, R., Lawpoolsri Niyom, S., Thitithanyanont, A., Hansasuta, P., Pornprasit, K., Chaiyaroj, S., Pitisuttithum, P.
10.1101/2022.10.02.22280572 — Posted: 2022-10-03
Reproducibility of spatial summation of pain effect during COVID-19 pandemic
Nastaj, J., Skalski, J., Budzisz, A., Szikszay, T. M., Swoboda, S., Kowalska, W., Nowak, D., Zbroja, E., Kruszyna, N., Jakubinska, M., Grygny, D., Polczyk, R., Malecki, A., Luedtke, K., Adamczyk, W. M.
10.1101/2022.09.30.510274 — Posted: 2022-10-03
Intranasal delivery of NS1-deleted influenza virus vectored COVID-19 vaccine restrains the SARS-CoV-2 inflammatory response
Zhang, L., Jiang, Y., He, J., Chen, J., Qi, R., Yuan, L., Shao, T., Chen, C., Chen, Y., Wang, X., Lei, X., Gao, Q., Zhuang, C., Zhou, M., Ma, J., Liu, W., Yang, M., Fu, R., Wu, Y., Chen, F., Xiong, H., Nie, M., Chen, Y., Wu, K., Fang, M., Wang, Y., Zheng, Z., Huang, S., Ge, S., Cheng, S.-C., Zhu, H., Chen, T., Yuan, Q., Wu, T., Zhang, J., Chen, Y., Zhang, T., Qi, H., Guan, Y., Xia, N.
10.1101/2022.10.03.510566 — Posted: 2022-10-03
CiDRE+ M2c macrophages hijacked by SARS-CoV-2 cause COVID-19 severity
Mitsui, Y., Suzuki, T., Kuniyoshi, K., Inamo, J., Yamaguchi, K., Komuro, M., Watanabe, J., Edamoto, M., Li, S., Kouno, T., Oba, S., Hosoya, T., Koyama, S., Sakaguchi, N., Standley, D. M., Shin, J. W., Akira, S., Yasuda, S., Miyazaki, Y., Kochi, Y., Kumanogoh, A., Okamoto, T., Satoh, T.
10.1101/2022.09.30.510331 — Posted: 2022-10-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).